LABORATOIRES YOLLA
ActiveSummary
LABORATOIRES YOLLA has been active since 1982 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show negative equity (-€39,882) and a net result of -€21,541. Equity fluctuates too strongly from year to year to read a trend from it. Its solvency ranks better than 15% of 145 sector peers (NACE 20, financial year 2025). The computed 12-month bankruptcy probability is 0.7% (low).
Overview
Official details
Source: KBO- Status
- Active since 04-01-1982 Normal situation
- Activity
- Manufacture of chemicals and chemical products NACE 20420
- Joint committee
- 207 Paritair Comité voor de bedienden uit de scheikundige nijverheid · annual accounts 2025
- Establishment unit
- 2.020.087.554 1080 Sint-Jans-Molenbeek, since 04-01-1982
- Financial year end
- 31 December
- Peppol
- Reachable since 25-11-2025
Financial position
- Bankruptcy probabilitywithin 12 months
- 0.7%
- Gross margin
- €52,722
- ▲ 4.6%
- Turnover
- ≈ €160,000
- estimated
- Loss
- €21,541
- ▲ 143%
- Equity
- -€39,882
- ▼ 117%
- Total assets
- €52,542
- ▼ 4.6%
- Employees on 31-12-2025
- 1
- =
- Negative equity on 31-12-2025
Score breakdownraises riskCapped at 59: negative equityNegative equity -€39,882Loss of €21,541, the second in a row (financial year 2025)lowers riskSize: total assets €52,542Founded in 1982Show the evidence
Checked score
About 7 in 1,000 comparable companies go bankrupt within 12 months (an estimate).
Calculation
The band follows from the bankruptcy probability. 10 more points roughly halve it.
| 75-100 | Excellent | under 0.55% |
| 60-74 | Healthy | 0.55% to 1.5% |
| 45-59 | Fair | 1.5% to 4.2% |
| 25-44 | Weak | 4.2% to 15.0% |
| 0-24 | Critical | over 15.0% |
Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 20, micro). It does better than 10% of them on solvency, 50% on liquidity, 11% on profitability and 8% on growth.
The bankruptcy probability was computed on 03-11-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.
Some facts cap the score, however low the probability. With negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late, the score is Fair at most (59). With two missing filings, it is Weak at most (44). During a judicial reorganisation or at the company's end (bankruptcy, dissolution, liquidation), it is Critical at most (24).
Credit check for an amount and term of your choice
Show the recommended maximum and see how the verdict changes with amount, term and advance.
The scores and ratios are Checked's own calculations, not a credit decision.
Signals
The company filed its last 7 accounts on average 32 days before the deadline. In the sector (NACE 20), the median for financial year 2024 was 22 days before the deadline, and 26% of those companies filed late.
Searched, nothing found (2)
Key points
- Risk: Negative equitydebts exceed assets in financial year 2025 -€39,882 View
- Risk: 4 loss-making years in a rowloss in financial year 2025 -€21,541 View
- Caution: Lower solvency than 85% of companies in chemicalssector median 24.0% · 145 companies -75.9% View
- Positive: Filed on time since financial year 2018accounts within the deadline every year 8 years View
Recent changes
- · Gazette deed Change of role: GLASER Claudine, from manager to director
Comparable companies
These companies have the same main activity as LABORATOIRES YOLLA: manufacture of chemicals and chemical products (NACE 20420). They are comparable in size and age: total assets between €18,900 and €297,000, founded between 1946 and 2001.
| Company | Total assets | Gross margin |
|---|---|---|
| LABORATOIRES YOLLA Sint-Jans-Molenbeek | €52,542 | €52,722 |
| SATIVALL Thuin | €111,399 | €48,308 |
| Les Ateliers M. Moureau Anderlecht | €18,862 | €67,406 |
| CHEMCOM Waterloo | €136,368 | €40,372 |
| DISTRILENE Heist-op-den-Berg | €296,882 | €106,960 |
| CALYPSO MARKETING La Hulpe | €293,535 | €106,661 |
| ALLOPHARM.BE Waremme | €19,980 | €5,901 |
Key facts about LABORATOIRES YOLLA
- What is the company number of LABORATOIRES YOLLA?
- The company number of LABORATOIRES YOLLA is 0422.289.894. The VAT number is the same number with BE in front: BE 0422.289.894.
- Where is LABORATOIRES YOLLA based?
- The registered office is at Hovenierstraat 85, 1080 Sint-Jans-Molenbeek.Company details
- What does LABORATOIRES YOLLA do?
- According to the KBO register, the main activity is manufacture of chemicals and chemical products (NACE 20420).
- What is the legal form of LABORATOIRES YOLLA?
- The legal form of LABORATOIRES YOLLA is Private limited company (BV).
- When was LABORATOIRES YOLLA founded?
- LABORATOIRES YOLLA was founded on 04-01-1982.
- Is LABORATOIRES YOLLA still active?
- Yes, LABORATOIRES YOLLA is an active enterprise in the KBO register.
- How many employees does LABORATOIRES YOLLA have?
- LABORATOIRES YOLLA had an average of 1 full-time equivalents in financial year 2025, according to the filed annual accounts.Financials
- Which joint committee does LABORATOIRES YOLLA fall under?
- In its 2025 annual accounts, LABORATOIRES YOLLA states joint committee 207 (Paritair Comité voor de bedienden uit de scheikundige nijverheid).
- What is the turnover of LABORATOIRES YOLLA?
- The turnover in financial year 2025 is ≈ €160,000. This figure is estimated from the gross margin of €52,722 and 2,666 comparable companies of the same size. It probably lies between €100,000 and €270,000. It is a rough estimate.
- Is LABORATOIRES YOLLA profitable?
- In financial year 2025, LABORATOIRES YOLLA made a loss of €21,541.
- Where can I find the annual accounts of LABORATOIRES YOLLA?
- LABORATOIRES YOLLA filed 44 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
- When are the next annual accounts of LABORATOIRES YOLLA due?
- LABORATOIRES YOLLA must file the annual accounts for financial year 2026 by 31-07-2027.Timeline
Next steps
See how customers, suppliers and banks see your own company and what to improve first.